PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-60

  1. 3,768 Posts.
    lightbulb Created with Sketch. 1548
    This was also written in the previous quarterly:

    “Research and development expenditure for the quarter was $21.9m compared to the previous quarter of $16.15m.

    The anticipated spend for Q2 FY24 is expected to be at a lower level to the previous two quarters. ”

    The forecasts are worth the paper they are written on.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.0¢ 24.0¢ 23.0¢ $81.47K 346.9K

Buyers (Bids)

No. Vol. Price($)
4 110909 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 125452 12
View Market Depth
Last trade - 13.50pm 21/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.